High Insulin Levels Genetically Linked to Lower Lipoprotein(a)
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- There is an association between genetically predicted increased insulin concentrations and decreased concentrations of circulating lipoprotein(a) (Lp[a]), according to a study published online Aug. 29 in Cardiovascular Diabetology to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in London.
Mateusz Lejawa, from the University of Silesia in Katowice, Poland, and colleagues examined the relationship between genetically predicted insulin concentrations and Lp(a) levels. The analysis included genetic variants strongly associated with fasting insulin levels from meta-analyses of genome-wide association studies in European populations (151,013 individuals) and summary-level data for Lp(a) from 361,194 participants in the U.K. Biobank.
The researchers found that genetically predicted fasting insulin levels were negatively associated with Lp(a) levels (β = −0.15). A sensitivity analysis supported a causal relationship between genetically predisposed insulin levels and Lp(a) using the weighted median method (β = −0.26), but not the Mendelian randomization-Egger method (β = −0.22).
"These findings suggest that hyperinsulinemia, which typically accompanies type 2 diabetes, can partially explain the inverse relationship between low Lp(a) concentrations and an increased risk of type 2 diabetes," the authors write. "Further studies are needed to validate and establish the exact mechanism behind this relationship."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
TUESDAY, May 13, 2025 -- Patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.